Thomson Reuters Corp. (NYSE: TRI) announced Monday that it has acquired GeneGo, a leading provider of biology and disease information ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE